Emiliano Antiga Selected Research

Dermatitis Herpetiformis (Disease, Duhring's)

2/2021	Granular Deposits of IgA in the Skin of Coeliac Patients Without Dermatitis Herpetiformis: A Prospective Multicentric Analysis.
1/2021	T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?
6/2019	Could anti-glycan antibodies be useful in dermatitis herpetiformis?
1/2019	Female Patients with Dermatitis Herpetiformis Show a Reduced Diagnostic Delay and Have Higher Sensitivity Rates at Autoantibody Testing for Celiac Disease.
1/2019	Granular IgA Deposits in the Skin of Patients with Coeliac Disease: Is it Always Dermatitis Herpetiformis?
1/2015	Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis.
1/2013	Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
1/2012	Dermatitis herpetiformis: from the genetics to the development of skin lesions.
1/2012	Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy.
8/2011	Gluten-free diet in patients with dermatitis herpetiformis: not only a matter of skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emiliano Antiga Research Topics

Disease

10	Dermatitis Herpetiformis (Disease, Duhring's) 02/2021 - 08/2011
9	Skin Diseases (Skin Disease) 09/2021 - 12/2005
6	Bullous Pemphigoid (Pemphigoid) 01/2022 - 11/2005
4	Celiac Disease (Celiac Sprue) 01/2019 - 01/2012
3	Pemphigus (Pemphigus Vulgaris) 08/2021 - 07/2007
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2018 - 12/2012
2	Vasculitis (Vasculitides) 01/2022 - 12/2020
2	Linear IgA Bullous Dermatosis 08/2021 - 01/2020
2	Neoplasms (Cancer) 08/2021 - 12/2020
2	Pruritus (Itching) 08/2021 - 03/2007
2	Skin Manifestations 01/2019 - 01/2015
2	Cutaneous Lupus Erythematosus 01/2016 - 12/2007
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2022
1	Psoriatic Arthritis 01/2022
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 10/2021
1	Pain (Aches) 03/2021
1	Blister (Bulla) 01/2021
1	Infections 12/2020
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 05/2020
1	Atrophy 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Wells syndrome 01/2019
1	Benign Familial Pemphigus (Hailey Hailey Disease) 06/2012
1	Urticaria (Hives) 03/2007
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2007
1	Erythema Multiforme 01/2007
1	Atopic Dermatitis (Atopic Eczema) 07/2006
1	Chronic Disease (Chronic Diseases) 07/2006
1	Drug Eruptions (Drug Eruption) 12/2005
1	Lichenoid Eruptions 12/2005
1	Lichen Planus (Lichen Ruber Planus) 12/2005
1	Systemic Scleroderma (Systemic Sclerosis) 12/2005

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 01/2022 - 01/2013
7	Immunoglobulin A (IgA)IBA 02/2021 - 01/2013
5	Glutens (Glutelin)IBA 01/2019 - 01/2012
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2013
3	AntigensIBA 01/2022 - 08/2016
3	AntibodiesIBA 08/2021 - 06/2019
2	KalininIBA 08/2021 - 08/2016
2	Matrix Metalloproteinases (MMPs)IBA 08/2021 - 08/2016
2	Rituximab (Mabthera)FDA Link 01/2021 - 01/2019
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2019 - 01/2013
2	Acitretin FDA Link 07/2018 - 12/2012
2	CurcuminIBA 07/2018 - 01/2015
2	CD40 Ligand (CD40L)IBA 12/2007 - 07/2007
1	Neutralizing AntibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Collagen Type XVIIIBA 01/2022
1	VaccinesIBA 10/2021
1	CannabidiolIBA 09/2021
1	Indicators and Reagents (Reagents)IBA 08/2021
1	AnkyrinsIBA 03/2021
1	TransglutaminasesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Desmoglein 1IBA 01/2021
1	Desmoglein 3IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	NivolumabIBA 11/2020
1	LymecyclineIBA 11/2019
1	Polysaccharides (Glycans)IBA 06/2019
1	Omalizumab (Xolair)FDA Link 01/2019
1	CholesterolIBA 07/2018
1	LipidsIBA 07/2018
1	IntegrinsIBA 08/2016
1	Collagen Type VIIIBA 08/2016
1	HomocysteineIBA 01/2016
1	LecithinsIBA 01/2015
1	SteroidsIBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	Interleukin-22 (IL-22)IBA 01/2015
1	AntioxidantsIBA 01/2015
1	Dapsone FDA Link 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	GliadinIBA 01/2013
1	EpitopesIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Etanercept (Enbrel)FDA Link 12/2012
1	Methotrexate (Mexate)FDA LinkGeneric 06/2012
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 07/2007
1	EnzymesIBA 07/2007
1	Messenger RNA (mRNA)IBA 07/2007
1	ImmunosorbentsIBA 07/2007
1	Histamine Antagonists (Antihistamines)IBA 03/2007
1	Chemokine CCL17IBA 01/2007
1	Interleukin-12 (IL 12)IBA 01/2007
1	ChemokinesIBA 01/2007
1	Fas Ligand Protein (Fas Ligand)IBA 01/2007
1	hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric 07/2006
1	Ointments (Pastes)IBA 07/2006
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2006
1	Sildenafil Citrate (Viagra)FDA Link 12/2005
1	Penicillamine (Cuprimine)FDA Link 12/2005

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2015
2	Gluten-Free Diet 01/2015 - 08/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Drug Therapy (Chemotherapy) 01/2019